Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Andrew M Jones

3PUBLICATIONS
22CO-AUTHORS
Behavioural epidemiologyFluid-structure interaction and aeroacousticsProsthetics and orthotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Aug 28, 2025
The Impact of Attention Deficit Hyperactivity Disorder on Home Spirometry and Other Parameters in People With Cystic Fibrosis.

Aqeem Azam, Peter James Barry, Rowland J Bright-Thomas

|May 30, 2025
Effect of elexacaftor/tezacaftor/ivacaftor on systemic inflammation in cystic fibrosis.

Rosemary E Maher, Urszula M Cytlak-Chaudhuri, Saad Aleem

|Dec 02, 2024
Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life.

Elizabeth Clarke, Julia Taylor, Pippa Watson

Pageof 1

Frequent Collaborators

2 joint publications

Alex Horsley

1 joint publications

Elizabeth Clarke

1 joint publications

Julia Taylor

1 joint publications

Jane Freeston

1 joint publications

Daniel Peckham

1 joint publications

Urszula M Cytlak-Chaudhuri

1 joint publications

Saad Aleem

1 joint publications

Peter Barry

1 joint publications

Daniel Paul Brice

1 joint publications

Eva Caamaño Gutiérrez

Frequent Collaborators

2 joint publications

Alex Horsley

1 joint publications

Elizabeth Clarke

1 joint publications

Julia Taylor

1 joint publications

Jane Freeston

Top Related Videos

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
07:38

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome

Published on : Aug 03, 2021

2.4K
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.4K
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on : Jan 12, 2019

10.3K
See more related videos

Top Related Videos

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
07:38

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome

Published on : Aug 03, 2021

2.4K
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.4K
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on : Jan 12, 2019

10.3K
See more related videos